NIFTY 50▼23,995.35
-309.00 (-1.27%)
SENSEX▼78,782.24
-941.88 (-1.18%)
NIFTY BANK▼51,215.25
-458.65 (-0.89%)
TATA MOTORS▼824.10
-19.35 (-2.29%)
SUZLON ENERGY▼66.32
-1.82 (-2.67%)
TATA STEEL▼146.95
-2.80 (-1.87%)
INDIAN RAILWAY FINANCE CORP▼153.24
-4.87 (-3.08%)
TATA POWER▼429.05
-16.40 (-3.68%)
RAIL VIKAS NIGAM▼446.20
-24.75 (-5.26%)
RELIANCE INDUSTRIES▼1,302.15
-36.50 (-2.73%)
VODAFONE IDEA▼7.88
-0.57 (-6.75%)
ZOMATO▼245.08
-3.91 (-1.57%)
RELIANCE POWER▼42.03
-1.00 (-2.32%)
INDIAN RENEWABLE ENERGY▼205.38
-6.60 (-3.11%)
ADANI POWER▼585.00
-12.35 (-2.07%)
YES BANK▼20.33
-0.38 (-1.83%)
STATE BANK OF INDIA▲829.85
8.65 (1.05%)
NHPC▼83.30
-0.83 (-0.99%)
HDFC BANK▼1,714.10
-23.20 (-1.34%)
OLA ELECTRIC MOBILITY LTD▼80.84
-2.00 (-2.41%)
JIO FIN SERVICES LTD▼319.85
-6.35 (-1.95%)
INDIAN OIL CORP▼138.93
-6.06 (-4.18%)
BHARAT ELECTRONICS▼284.15
-4.50 (-1.56%)
MRF▼1,20,876.75
-2453.55 (-1.99%)
GTL INFRA▼2.11
-0.07 (-3.21%)
ADANI PORT & SEZ▼1,349.25
-45.15 (-3.24%)
JAIPRAKASH POWER VENTURES▼17.88
-0.59 (-3.19%)
ITC▼484.60
-5.70 (-1.16%)
Eris Lifesciences Share Price
ERIS
₹1,315.00-₹32.15 (-2.39%) TodayLast updated on 04 Nov, 2024 | 15:29 IST
Eris Lifesciences Share Price Chart
Please wait...
About Eris Lifesciences
Eris Lifesciences Financials
Market cap ₹17,933 Crs | Open ₹1,345.00 | Close ₹1,347.15 |
Circuit range ₹1,581.05 - ₹1,054.05 | Day range ₹1,302.00 - ₹1,347.15 | Year range ₹809.15 - ₹1,522.05 |
Volume 67,879 | Avg. traded ₹1,315.88 | Revenue (12m) ₹2,498 Crs |
Eris LifesciencesEris Lifesciences Limited is an India-based company that is primarily engaged in the manufacturing and marketing of pharmaceutical products. The Company’s manufacturing plant is located in Guwahati, Assam. Its therapeutic areas include oral diabetes care, cardiac care, pain/analgesics, gynecology, gastrointestinal, central nervous system (CNS), and vitamins, minerals, and nutrients (VMN). The Company's brands include Advog 0.2, Atorsave Gold 10, Baga NT 100, Calshine 60K Tablet, Carpela, Cilentra Plus 5, Cognix, D1000cal, Enoxsave 60, Glimisave M 4 forte, Levroxa 1000, Mac Rabonik Plus, Glimisave, Eritel, Renerve, Tendia, Olmin, Rabonik, Tayo, Cyblex, Lnbloc, Remylin, Zomelis, Crevast, Atorsave, Ginkocer and Metital. The Company’s wholly owned subsidiaries include Kinedex Healthcare Private Limited, Aprica Healthcare Limited, and Eris Healthcare Private Limited.
Eris Lifesciences Key indicators
52 week high ₹1,522.05 | 52 week low ₹809.15 | P/E ratio 51.52 |
P/B ratio 6.42 | ROE 12.65% | ROCE 10.17% |
Dividend yield -- | Debt/Equity ratio 1 | EPS 22.03 |
Learn more
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
88%
Hold
12%
Sell
0%
This analysis is based on the reviews of 8 experts in the last 7 days
Eris Lifesciences Fundamentals
Eris Lifesciences Financial Ratios
Operating profit margin31.28% | Net profit margin19.19% |
ROE12.65% | ROA7.79% |
ROCE10.17% |
Learn more
Eris Lifesciences Share Price history
Day | Open | Close | Change % |
---|---|---|---|
Mon, Nov 4 2024 | ₹1,345.00 | ₹1,317.55 | -2.20% |
Fri, Nov 1 2024 | ₹1,327.00 | ₹1,347.15 | |
Thu, Oct 31 2024 | ₹1,280.00 | ₹1,323.15 | |
Wed, Oct 30 2024 | ₹1,302.55 | ₹1,290.10 | -0.96% |
Tue, Oct 29 2024 | ₹1,289.00 | ₹1,302.55 | |
Mon, Oct 28 2024 | ₹1,274.35 | ₹1,281.00 | -0.85% |
Fri, Oct 25 2024 | ₹1,282.50 | ₹1,292.00 | |
Thu, Oct 24 2024 | ₹1,272.00 | ₹1,283.80 |
Events
Corporate actions
Dividend • ₹7.35/share
Ex date 11 Aug 2022
Learn more
More